Oncology
Exosome Diagnostics Announces Dr. John Holaday Will Join Its Board of Directors
Published in Gastroenterology Week, January 12th, 2009
Exosome Diagnostics, Inc., the developer of proprietary genetics-based diagnostic tests with applications in oncology and metabolic disease, announced that John Holaday, Ph.D. has joined the Companyˇ¦s Scientific Board of Directors. Dr. Holaday, formerly listed among the 500 most cited scientists in the world by the Science Citation Index, will play a key role in Exosome Diagnosticsˇ¦ efforts to commercialize proprietary genetics based diagnostics of new cancers, identify the occurrence of post operative cancers, and more precisely monitor the efficacy of drug therapies in oncology and endocrinology.
ˇ§Dr. Holadayˇ¦s business and clinical development acumen offers a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American Journal of Pathology
Safe new therapy for genetic heart disease - World Journal of Gastroenterology
A new screening test for chronic abdominal pain - World Journal of Gastroenterology
Acute gastric injury due to high-dose analgesics? - World Journal of Gastroenterology
How to enhance non-thermal effects of ultrasound - World Journal of Gastroenterology
What are protective effects of anti-ricin A-chain aptamer? - Acid Reflux Disease
Report summarizes acid reflux disease study findings from Ohio State University - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
